The authors have noticed that Figure 1 was published incorrectly in the original version of this Article. The correct Figure 1 appears below.
Schematic of ubiquinone-CdSe/ZnS QDs as redox fluorescence biosensor for Parkinson's disease diagnosis.
(a), Ubiquinone-terminated disulphides (QnNS) synthesis and self-assembly of QnNS on to CdSe/ZnS QDs. (b), Conceptual visualisation of QnNS-QDs as complex I sensor in vitro. Under oxidized state (QnNS), ubiquinone functions as a favorable electron acceptor, this results in effective QDs' fluorescence quenching. Addition of complex I to QnNS-QDs solution in the presence of NADH, ubiquinone coupled electron transfer and proton translocation from NADH, producing reduced ubiquinol (HQnNS) form on the surface of QDs to mimic the initial stages of the respiratory chain. Ubiquinol when in close proximity to the QDs produces fluorescence enhancement. (c), Energetic diagram of the QDs bioconjugates between QDs and QnNS/HQnNS. (d), Fluorescence spectra of ubiquinone/ubiquinol- functionalised CdSe/ZnS QDs. (e), Cyclic voltammetry of QnNS-CdSe/ZnS QDs. (f), Visualisation of QnNS-CdSe/ZnS QDs as an intracellular complex I sensor. The mitochondrial-specific neurotoxin, rotenone, inhibits complex I and leads to Parkinson's-like pathogenesis. Parkinson's disease is characterised by impaired activity of complex I in mitochondria.
Additional information
The online version of the original article can be found at 10.1038/srep01537
Rights and permissions
About this article
Cite this article
Ma, W., Qin, LX., Liu, FT. et al. Correction: Corrigendum: Ubiquinone-quantum dot bioconjugates for in vitro and intracellular complex I sensing. Sci Rep 3, 1724 (2013). https://doi.org/10.1038/srep01724
Published:
DOI: https://doi.org/10.1038/srep01724
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
